How to buy Brainsway stock (BWAY)

Brainsway is a medical devices business based in the US. Brainsway shares (BWAY) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $9.24 – a decrease of 1.91% over the previous week. Brainsway employs 134 staff and has a trailing 12-month revenue of around $36.4 million.

Our top picks for where to buy Brainsway stock

Buy Brainsway stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Brainsway stock price (NASDAQ: BWAY)

Use our graph to track the performance of BWAY stocks over time.

Brainsway shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$9.24
52-week range	$4.61 - $10.98
50-day moving average more info button	$9.87
200-day moving average more info button	$7.37
Wall St. target price	$13.73
PE ratio more info button	114.375
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.08

Is it a good time to buy Brainsway stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Brainsway price performance over time

Historical closes compared with the close of $8.96 from 2024-12-19

1 week (2024-12-13)	-4.88%
1 month (2024-11-21)	-8.94%
3 months (2024-09-20)	10.62%
6 months (2024-06-21)	45.45%

1 year (2023-12-21)	29.29%
2 years (2022-12-21)	275.37%
3 years (2021-12-21)	19.31%
5 years (2019-12-20)	9.65

Is Brainsway stock undervalued or overvalued?

Valuing Brainsway stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Brainsway's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Brainsway's P/E ratio

Brainsway's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 114x. In other words, Brainsway shares trade at around 114x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Brainsway's EBITDA

Brainsway's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.8 million.

The EBITDA is a measure of a Brainsway's overall financial performance and is widely used to measure a its profitability.

Brainsway financials

Revenue TTM	$36.4 million
Operating margin TTM	5.86%
Gross profit TTM	$20 million
Return on assets TTM	0.73%
Return on equity TTM	1.44%
Profit margin	1.67%
Book value	$1.25
Market Capitalization more info button	$172.1 million

TTM: trailing 12 months

Brainsway share dividends

We're not expecting Brainsway to pay a dividend over the next 12 months.

Brainsway share price volatility

Over the last 12 months, Brainsway's shares have ranged in value from as little as $4.61 up to $10.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Brainsway's is 0.374. This would suggest that Brainsway's shares are less volatile than average (for this exchange).

Brainsway overview

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. .

Frequently asked questions

null
What percentage of Brainsway is owned by institutions?
Currently 19.223% of Brainsway shares are held by institutions. How many people work for Brainsway?
Latest data suggests 134 work at Brainsway. When does the fiscal year end for Brainsway?
Brainsway's fiscal year ends in December. Where is Brainsway based?
Brainsway's address is: Bynet Building, Jerusalem, Israel, 9777518 What is Brainsway's ISIN number?
Brainsway's international securities identification number is: US10501L1061 What is Brainsway's CUSIP number?
Brainsway's Committee on Uniform Securities Identification Procedures number is: 10501L106